Proliferative Diabetic Retinopathy (PDR) Unknown Status Phase 3 Trials for Ranibizumab (DB01270)

Back to Proliferative Diabetic Retinopathy (PDR)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

IndicationStatusPhase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00516464
Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring VitrectomyTreatment
NCT02447185
25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical TrialPrevention